$PRAN Headlines Prana Biotechnology up 19% in pr
Post# of 44845
Posted On: 02/05/2014 12:37:31 PM
$PRAN Headlines
Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy
What is Alzheimer’s? 11:29 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Help could be on the way for Alzheimer's 9:47 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Elan, Wyeth sink on Alzheimer's study 12:38 p.m. July 30, 2008 - Val Brickates Kennedy
Baidu.com shares end lower; Novo Nordisk downgraded 5:32 p.m. Feb. 26, 2008 - Carla Mozee
Friday's biggest stock gainers and decliners 5:28 p.m. Oct. 13, 2006 - MarketWatch
Prana Biotech gets 'going concern' notice from auditors 7:41 a.m. Oct. 13, 2006 - Thomas Middleton
Prana Biotech gets "going concern" auditors notice 7:36 a.m. Oct. 13, 2006 - Thomas Middleton
Prana to begin Phase II trial of PBT2 drug in Q4 12:03 p.m. July 24, 2006 - Michael Baron
Prana shares up; co. developing PBT2 Alzheimer's treatment 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech volume 452,583 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech shares soar 70% to $2.80 12:03 p.m. July 24, 2006 - Michael Baron
Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher 9:54 a.m. Jan. 25, 2014 - Seeking Alpha
Prana Biotechnology Faces Major Upcoming Catalysts 9:59 a.m. Jan. 24, 2014 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Prana Biotech 8:21 a.m. Jan. 24, 2014 - TheStreet.com
Alzheimer’s Stocks Are a Stealth Opportunity 3:50 a.m. Dec. 10, 2013 - InvestorPlace.com
Given Imaging – Why Is GIVN Stock Soaring? 6:42 a.m. Dec. 9, 2013 - InvestorPlace.com
Phase II Results Approaching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
Phase II Results Approching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 10:48 a.m. Nov. 1, 2013 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 3:00 a.m. Aug. 21, 2013 - InvestorPlace.com
Still Time To Catch Big Growth In Biotech: George Zavoico 5:12 p.m. Aug. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 3:00 a.m. July 31, 2013 - InvestorPlace.com
Prana Completes Phase 2 Huntington Disease Trial With PBT2 7:10 a.m. July 23, 2013 - benzinga.com
Prana Announces Share Purchase Plan Closed 7:05 a.m. May 3, 2013 - benzinga.com
4 Healthcare Stock Stories Not To Be Overlooked 3:36 p.m. March 7, 2013 - Wall St. Cheat Sheet
Seven Highly Unusual Volume Spikes (BYD, MTG, NS, PANW, PRAN, SCSS, SSYS) 10:02 a.m. March 4, 2013 - 247WallSt.com
2 Speculative Biotech Stocks To Consider In The Wake Of Early-Stage Developments 3:52 p.m. Dec. 13, 2012 - Seeking Alpha
7 Innovative Biotechs That Could Soar By Year-End: George Zavoico 3:00 p.m. Sept. 13, 2012 - Seeking Alpha
Elan's Split Will Create 2 Very Different Companies 2:12 p.m. Aug. 14, 2012 - Seeking Alpha
Stock Analysis Recap: Here’s Why These Stocks Trended This Week 1:11 p.m. Nov. 27, 2011 - Wall St. Cheat Sheet
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 9:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 9:02 a.m. Dec. 9, 2013 - Marketwire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Prana's PBT2 Featured as a Top 10 Global Neuroscience Project 9:02 a.m. Nov. 19, 2013 - Marketwire
Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease 9:02 a.m. Nov. 18, 2013 - Marketwire
Prana Responds to Media Segment Under ASX Guidance Note 8 9:01 a.m. Nov. 15, 2013 - Marketwire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Prana's PBT2 Reverses Memory Loss in Normal Aging 9:07 a.m. Oct. 30, 2013 - Marketwire
Five Star Equities Issues New Research Reports on DSX, LAKE, PRAN and SWY 8:00 a.m. Sept. 16, 2013 - ACCESSWIRE
Prana Updates Progress on PBT2 Trials in Alzheimer's and Huntington's Diseases 8:01 a.m. Sept. 13, 2013 - Marketwire
Parkinson's UK Awards GBP 150,000 to Study Prana's PBT434 8:03 a.m. Sept. 4, 2013 - Marketwire
Five Star Equities Issues New Research Reports on ARQL, CYTK, HALO and PRAN 7:41 a.m. Sept. 4, 2013 - ACCESSWIRE
Prana Drug Treatment PBT2 Named One of Top Neuroscience Projects to Watch 8:02 a.m. Sept. 3, 2013 - Marketwire
Prana Prepares for Next Steps in the PBT2 Development Path to Market and Commercialization With Key Appointments Strategy 9:11 a.m. Aug. 1, 2013 - Marketwire
Five Star Equities Issues New Research Reports on HAE, PRAN, PRGO and SNTA 7:41 a.m. July 30, 2013 - ACCESSWIRE
Prana Doses First Patient in PBT2 Alzheimer's Extension Study 8:02 a.m. July 29, 2013 - Marketwire
Prana Completes Phase 2 Huntington Disease Trial With PBT2 8:03 a.m. July 23, 2013 - Marketwire
Prana Receives Approval for 12-Month Open-Label Extension Study in Alzheimer's Disease 8:30 a.m. July 3, 2013 - Marketwire
PBT434 Drug Candidate Shows Potential as "Next-Generation" Disease-Modifying Treatment in Parkinson's Disease 8:02 a.m. June 20, 2013 - Marketwire
Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy
What is Alzheimer’s? 11:29 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Help could be on the way for Alzheimer's 9:47 a.m. Aug. 14, 2008 - Val Brickates Kennedy
Elan, Wyeth sink on Alzheimer's study 12:38 p.m. July 30, 2008 - Val Brickates Kennedy
Baidu.com shares end lower; Novo Nordisk downgraded 5:32 p.m. Feb. 26, 2008 - Carla Mozee
Friday's biggest stock gainers and decliners 5:28 p.m. Oct. 13, 2006 - MarketWatch
Prana Biotech gets 'going concern' notice from auditors 7:41 a.m. Oct. 13, 2006 - Thomas Middleton
Prana Biotech gets "going concern" auditors notice 7:36 a.m. Oct. 13, 2006 - Thomas Middleton
Prana to begin Phase II trial of PBT2 drug in Q4 12:03 p.m. July 24, 2006 - Michael Baron
Prana shares up; co. developing PBT2 Alzheimer's treatment 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech volume 452,583 12:03 p.m. July 24, 2006 - Michael Baron
Prana Biotech shares soar 70% to $2.80 12:03 p.m. July 24, 2006 - Michael Baron
Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher 9:54 a.m. Jan. 25, 2014 - Seeking Alpha
Prana Biotechnology Faces Major Upcoming Catalysts 9:59 a.m. Jan. 24, 2014 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Prana Biotech 8:21 a.m. Jan. 24, 2014 - TheStreet.com
Alzheimer’s Stocks Are a Stealth Opportunity 3:50 a.m. Dec. 10, 2013 - InvestorPlace.com
Given Imaging – Why Is GIVN Stock Soaring? 6:42 a.m. Dec. 9, 2013 - InvestorPlace.com
Phase II Results Approaching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
Phase II Results Approching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease 12:00 p.m. Nov. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 10:48 a.m. Nov. 1, 2013 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 3:00 a.m. Aug. 21, 2013 - InvestorPlace.com
Still Time To Catch Big Growth In Biotech: George Zavoico 5:12 p.m. Aug. 15, 2013 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 3:00 a.m. July 31, 2013 - InvestorPlace.com
Prana Completes Phase 2 Huntington Disease Trial With PBT2 7:10 a.m. July 23, 2013 - benzinga.com
Prana Announces Share Purchase Plan Closed 7:05 a.m. May 3, 2013 - benzinga.com
4 Healthcare Stock Stories Not To Be Overlooked 3:36 p.m. March 7, 2013 - Wall St. Cheat Sheet
Seven Highly Unusual Volume Spikes (BYD, MTG, NS, PANW, PRAN, SCSS, SSYS) 10:02 a.m. March 4, 2013 - 247WallSt.com
2 Speculative Biotech Stocks To Consider In The Wake Of Early-Stage Developments 3:52 p.m. Dec. 13, 2012 - Seeking Alpha
7 Innovative Biotechs That Could Soar By Year-End: George Zavoico 3:00 p.m. Sept. 13, 2012 - Seeking Alpha
Elan's Split Will Create 2 Very Different Companies 2:12 p.m. Aug. 14, 2012 - Seeking Alpha
Stock Analysis Recap: Here’s Why These Stocks Trended This Week 1:11 p.m. Nov. 27, 2011 - Wall St. Cheat Sheet
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 9:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 9:02 a.m. Dec. 9, 2013 - Marketwire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Prana's PBT2 Featured as a Top 10 Global Neuroscience Project 9:02 a.m. Nov. 19, 2013 - Marketwire
Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease 9:02 a.m. Nov. 18, 2013 - Marketwire
Prana Responds to Media Segment Under ASX Guidance Note 8 9:01 a.m. Nov. 15, 2013 - Marketwire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Prana's PBT2 Reverses Memory Loss in Normal Aging 9:07 a.m. Oct. 30, 2013 - Marketwire
Five Star Equities Issues New Research Reports on DSX, LAKE, PRAN and SWY 8:00 a.m. Sept. 16, 2013 - ACCESSWIRE
Prana Updates Progress on PBT2 Trials in Alzheimer's and Huntington's Diseases 8:01 a.m. Sept. 13, 2013 - Marketwire
Parkinson's UK Awards GBP 150,000 to Study Prana's PBT434 8:03 a.m. Sept. 4, 2013 - Marketwire
Five Star Equities Issues New Research Reports on ARQL, CYTK, HALO and PRAN 7:41 a.m. Sept. 4, 2013 - ACCESSWIRE
Prana Drug Treatment PBT2 Named One of Top Neuroscience Projects to Watch 8:02 a.m. Sept. 3, 2013 - Marketwire
Prana Prepares for Next Steps in the PBT2 Development Path to Market and Commercialization With Key Appointments Strategy 9:11 a.m. Aug. 1, 2013 - Marketwire
Five Star Equities Issues New Research Reports on HAE, PRAN, PRGO and SNTA 7:41 a.m. July 30, 2013 - ACCESSWIRE
Prana Doses First Patient in PBT2 Alzheimer's Extension Study 8:02 a.m. July 29, 2013 - Marketwire
Prana Completes Phase 2 Huntington Disease Trial With PBT2 8:03 a.m. July 23, 2013 - Marketwire
Prana Receives Approval for 12-Month Open-Label Extension Study in Alzheimer's Disease 8:30 a.m. July 3, 2013 - Marketwire
PBT434 Drug Candidate Shows Potential as "Next-Generation" Disease-Modifying Treatment in Parkinson's Disease 8:02 a.m. June 20, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼